IRF4 ablation in B cells abrogates allogeneic B cell responses and prevents chronic transplant rejection

MLA

Stephanie G. Yi, et al. “IRF4 Ablation in B Cells Abrogates Allogeneic B Cell Responses and Prevents Chronic Transplant Rejection.” The Journal of Heart and Lung Transplantation, vol. 40, Oct. 2021, pp. 1122–32. EBSCOhost, https://doi.org/10.1016/j.healun.2021.06.008.

APA

Stephanie G. Yi, Dawei Zou, Yixuan Wang, Wenhao Chen, Xian Chang Li, A. Osama Gaber, Guohua Wang, & Nancy M. Gonzalez. (2021). IRF4 ablation in B cells abrogates allogeneic B cell responses and prevents chronic transplant rejection. The Journal of Heart and Lung Transplantation, 40, 1122–1132. https://doi.org/10.1016/j.healun.2021.06.008

Chicago

Stephanie G. Yi, Dawei Zou, Yixuan Wang, Wenhao Chen, Xian Chang Li, A. Osama Gaber, Guohua Wang, and Nancy M. Gonzalez. 2021. “IRF4 Ablation in B Cells Abrogates Allogeneic B Cell Responses and Prevents Chronic Transplant Rejection.” The Journal of Heart and Lung Transplantation 40 (October): 1122–32. doi:10.1016/j.healun.2021.06.008.